These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34904007)

  • 1. Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI).
    Khorolskiy M; Ramenskaya G; Vlasov A; Perederyaev O; Maslennikova N
    Iran J Pharm Res; 2021; 20(3):541-552. PubMed ID: 34904007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
    Gopireddy RR; Maruthapillai A; Mahapatra S
    J Chromatogr Sci; 2024 Feb; 62(2):147-167. PubMed ID: 35830866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
    J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
    Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
    J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
    Mavis ME; Goksu Gursu G; Ular Cagatay N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an analytical method for trace-level quantification of genotoxic nitrosamine impurities in losartan and hydrochlorothiazide fixed-dose combination tablets using ultra performance liquid chromatography triple quadrupole mass spectrometry.
    Patel R; Purohit S; Solanki R; Khunt D; Patel C; Patel R; Parikh S
    Rapid Commun Mass Spectrom; 2023 Apr; 37(8):e9488. PubMed ID: 36740827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Estimation of Six Nitrosamine Impurities in Valsartan Using Liquid Chromatographic Method.
    Bodiwala KB; Panchal BG; Savale SS; Dave JB; Sureja DK; Dhameliya TM; Chhabria MT
    J AOAC Int; 2022 Feb; 105(1):1-10. PubMed ID: 34338773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl-Biphenyl-Tetrazole Impurities in Losartan.
    Luan NM; Khuyen VTK; Tuan ND
    J Sep Sci; 2024 Oct; 47(19):e202400277. PubMed ID: 39385440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry.
    Solanki R; Wadhwana P; Patel R; Gayakvad B; Kothari C; Patel C
    J Pharm Sci; 2023 May; 112(5):1268-1276. PubMed ID: 36822274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
    Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
    J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of GC-MS/MS Method for Simultaneous Estimation of Four Nitrosoamine Genotoxic Impurities in Valsartan.
    Tummala SR; Amgoth KP
    Turk J Pharm Sci; 2022 Aug; 19(4):455-461. PubMed ID: 36047600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
    Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
    J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory Updates and Analytical Methodologies for Nitrosamine Impurities Detection in Sartans, Ranitidine, Nizatidine, and Metformin along with Sample Preparation Techniques.
    Shaik KM; Sarmah B; Wadekar GS; Kumar P
    Crit Rev Anal Chem; 2022; 52(1):53-71. PubMed ID: 32691615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and determination of selected angiotensin II receptor antagonist group drugs by HPLC method.
    Czerwińska K; Mazurek AP
    Acta Pol Pharm; 2011; 68(6):831-7. PubMed ID: 22125946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective, green HPLC determination of losartan, valsartan and their nitrosodiethylamine impurity: application to pharmaceutical dosage forms.
    Abd El-Hay SS; Elhenawee M; Maged K; Ibrahim AE
    R Soc Open Sci; 2022 Jun; 9(6):220250. PubMed ID: 35706671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches.
    Bhirud D; Agrawal G; Shah H; Patel A; Palkar MB; Bhattacharya S; Prajapati BG
    Curr Top Med Chem; 2024; 24(6):503-522. PubMed ID: 38321910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of anti- hypertensive drugs on dried blood spots using a fluorescence detector--method development and validation.
    Rao RN; Bompelli S; Maurya PK
    Biomed Chromatogr; 2011 Nov; 25(11):1252-9. PubMed ID: 21308705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a HPLC method for 4,7-phenanthroline-5,6-dione I and identification of its major impurity by HPLC-MS-APCI.
    Shabir GA; Forrow NJ
    J Chromatogr Sci; 2005 Apr; 43(4):207-12. PubMed ID: 15975237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of four genotoxic impurities in gefitinib].
    Sun C; Ji Y; Qin K; Gao X; Zhao L
    Se Pu; 2019 Dec; 37(12):1297-1304. PubMed ID: 34213131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.